Vadodara, India

Sunil Sanghani

This inventor holds 2 USPTO granted patents. Top assignee: Alembic Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sunil Sanghani. Retrieved from https://idiyas.com/inventor/sunil-sanghani-qm5g8198

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sunil Sanghani: Innovator in Pharmaceutical Processes

Introduction

Sunil Sanghani is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of teriflunomide. With a total of 2 patents to his name, Sanghani's work is recognized for its innovation and impact.

Latest Patents

Sanghani's latest patents include a process for the preparation of teriflunomide. The first patent provides a detailed methodology for preparing teriflunomide of formula (I). The second patent also relates to a process for preparing teriflunomide of formula (I), showcasing his dedication to advancing pharmaceutical processes.

Career Highlights

Sunil Sanghani is currently employed at Alembic Limited, a prominent pharmaceutical company. His role at Alembic Limited allows him to apply his expertise in drug development and innovation. His contributions have been instrumental in enhancing the company's research capabilities.

Collaborations

Sanghani has collaborated with notable coworkers, including Keshav Deo and Samir Patel. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

Sunil Sanghani's work in the pharmaceutical industry exemplifies the spirit of innovation. His patents and collaborations highlight his commitment to advancing drug development. His contributions continue to make a significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…